Brd4 is on the move during inflammation

Trends in Cell Biology

Volumn 24, Issue 11, 2014, Pages 615-616

  Xu, Yali ^a,b   Vakoc, Christopher R ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

BET bromodomain; Brd4; Enhancer; Inflammation; JQ1; NF kB; P65; Super enhancer

Indexed keywords

4 (4 CHLOROPHENYL) 2,3,9 TRIMETHYL 6H THIENO[3,2 F][1,2,4]TRIAZOLO[4,3 A][1,4]DIAZEPINE 6 ACETIC ACID TERT BUTYL ESTER; BRD4 PROTEIN; DNA; HISTONE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR RELA;

DRUG TARGETING; ENDOTHELIUM CELL; ENHANCER REGION; GENE EXPRESSION; HISTONE ACETYLATION; INFLAMMATION; MACROPHAGE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; SHORT SURVEY; ANIMAL; ANTAGONISTS AND INHIBITORS; ATHEROSCLEROSIS; GENETICS; HUMAN; IMMUNOLOGY;

ANIMALS; ATHEROSCLEROSIS; HUMANS; INFLAMMATION; NF-KAPPA B P50 SUBUNIT; NUCLEAR PROTEINS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS;

EID: 84927696181     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2014.09.005     Document Type: Short Survey

References (10)

1. Spitz F., Furlong E.E.M. Transcription factors: from enhancer binding to developmental control. Nat. Rev. Genet. 2012, 13:613-626.
2. Heinz S., et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 2010, 38:576-589.
3. Jin F., et al. A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature 2013, 503:290-294.
4. Kaikkonen M.U., et al. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol. Cell 2013, 51:310-325.
5. Ostuni R., et al. Latent enhancers activated by stimulation in differentiated cells. Cell 2013, 152:157-171.
6. Smith E., Shilatifard A. Enhancer biology and enhanceropathies. Nat. Struct. Mol. Biol. 2014, 21:210-219.
7. Lovén J., et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 2013, 153:320-334.
8. Huang B., et al. Brd4 coactivates transcriptional activation of NF-κB via specific binding to acetylated RelA. Mol. Cell. Biol. 2009, 29:1375-1387.
9. Nicodeme E., et al. Suppression of inflammation by a synthetic histone mimic. Nature 2010, 468:1119-1123.
10. Brown J.D., et al. NF-kB directs dynamic super-enhancer formation in inflammation and atherogenesis. Mol. Cell 2014, 10.1016/j.molcel.2014.08.024.